The study, published in the European Journal of Epidemiology, drew on the Whitehall-1 Study, a legendary cohort of London civil servants first recruited between 1967 and 1970. Of the original 19,019 men, 8,537 survivors were resurveyed in 1997 and 1998, when their average age was 77. Researchers led by Sodiq Yusuff of the Clinical Trial Service Unit and Epidemiological Studies Unit at the University of Oxford focused on 4,582 men who had no prior diagnosis of cardiovascular disease or cancer, and tracked their deaths through national mortality registers until mid-2020. The result was an extraordinarily complete picture of mortality at the very end of life: during an average follow-up of 11.8 years, 4,194 of the participants, a staggering 91 percent, died, with more than 99 percent of those deaths occurring after age 70.

Participants reported their drinking habits through postal questionnaires. The researchers classified them as lifelong abstainers, ex-drinkers who had previously consumed alcohol but had stopped, or current regular drinkers, the latter divided into five bands of weekly intake ranging from fewer than 7 units per week to 42 or more. A single unit corresponds to 8 grams of pure alcohol, roughly half a standard glass of wine. Light drinkers consuming fewer than 7 units weekly served as the reference group, a deliberate choice designed to avoid the abstainer bias that has plagued earlier studies, where comparisons against non-drinkers can exaggerate apparent benefits of modest consumption.

The headline finding was stark. Men who drank 42 or more units per week, equivalent to roughly 21 pints of beer or more than two bottles of wine, faced a 38 percent higher risk of death from any cause compared with light drinkers, with a hazard ratio of 1.38 and a 95 percent confidence interval of 1.15 to 1.67. Ex-drinkers also fared poorly, showing a 21 percent elevated risk. Meanwhile, lifelong abstainers and those drinking 7 to 27 units per week showed no statistically significant difference from the light-drinking reference group. Among current drinkers, each additional 10 units of weekly alcohol was associated with a 5 percent increase in all-cause mortality risk.

When the researchers dissected deaths by cause, the excess risk concentrated overwhelmingly in non-vascular mortality. Heavy drinkers showed a 39 percent higher risk of non-vascular death, and the dose-response analysis pointed chiefly to alcohol-related cancers, where each additional 10 units per week carried a 19 percent higher risk. This aligns with long-standing evidence from the International Agency for Research on Cancer that alcohol is a carcinogen for multiple tumour types. By contrast, the association with vascular mortality was weaker and statistically uncertain, with a hazard ratio of 1.04 per 10 units per week and confidence intervals that crossed unity, leaving open the question of whether alcohol has any meaningful effect, protective or harmful, on heart disease and stroke deaths in this age group.

What makes this study particularly compelling is the methodological machinery deployed to dismantle the biases that have historically inflated the apparent benefits of moderate drinking. First, the team separated ex-drinkers from lifelong abstainers, a critical distinction because people who quit alcohol often do so precisely because illness has made drinking untenable, the so-called sick-quitter effect. Second, they excluded anyone with pre-existing vascular disease or cancer, removing those whose disease might have driven both their abstinence and their mortality. Third, they used light drinkers rather than abstainers as the reference category. Fourth, sensitivity analyses excluded deaths in the first five years of follow-up, and the core findings held firm. Finally, the researchers calculated E-values, a quantitative measure of how strong an unmeasured confounder would need to be to explain away the results. For heavy drinkers the E-value was 2.11, meaning only a very substantial hidden factor could account for the observed risk.

Even so, the authors are candid about the limits of their evidence. When deaths in the first ten years of follow-up were excluded, the associations became modest and non-significant, though the researchers note it is difficult to determine whether this reflects reverse causation or simply a loss of statistical power. When the analysis was restricted to never smokers, the associations attenuated, with wider confidence intervals, hinting at possible residual confounding by smoking or reduced precision in the smaller subgroup. The E-values for some categories, such as 1.30 for abstainers, suggest that relatively modest unmeasured confounding could account for those particular estimates. Alcohol intake was also measured only once, at the 1997-98 resurvey, so drinking patterns in middle age could not be accounted for, and self-reported consumption is inherently imprecise.

The study’s population also imposes constraints on generalisability. These were retired male civil servants, 94 percent of whom had held high employment grades at retirement, a strikingly privileged group compared with the broader British population. Survivor bias is another concern, since men alive at resurvey in their late seventies may represent a healthier subset of the original cohort, potentially over-representing light-to-moderate drinkers. The researchers could not assess binge drinking, beverage type, or drinking context, such as whether alcohol was consumed with meals. And the sample size, while sufficient for all-cause mortality, limited precision for vascular deaths and rarer cause-specific categories like dementia, pneumonia and infection, where the exploratory analyses were likely underpowered.

Nevertheless, the broader picture painted by the study is consistent with the direction of modern alcohol epidemiology. Two previous meta-analyses encompassing more than four million participants across all adult ages, which carefully accounted for reverse causation, found no statistically significant mortality difference between abstainers and light-to-moderate drinkers. Mendelian randomisation studies, which use genetic variants as natural instruments to probe causality, have likewise shown strong linear associations between genetically predicted alcohol intake and all-cause mortality, with no protective signal for moderate consumption. The Whitehall-1 analysis now extends that convergence of evidence into the oldest age brackets, where the J-shaped curve has been most persistent and most seductive.

The public health implications are considerable. Populations across high-income countries are ageing rapidly, and regular alcohol consumption among older people is rising, with alcohol-related deaths in England recently reaching record highs. If the apparent cardioprotective halo around moderate drinking in old age is largely an artefact of sick-quitter bias, healthy-user bias and residual confounding, then there is no epidemiological basis for recommending alcohol as a longevity aid to elderly patients. The authors conclude that their findings support public health strategies to reduce population-level alcohol consumption in older people, and to prevent alcohol-related deaths in old age just as in middle age. For the millions of older adults who have clung to the idea that a daily drink is a prescription for a longer life, this study delivers an uncomfortable but rigorously argued correction: when it comes to alcohol and mortality in later life, more is worse, and less is probably not protective at all.

Subject of Research: Associations between alcohol consumption and cause-specific mortality in older men from the Whitehall-1 cohort

Article Title: Alcohol consumption and cause-specific mortality in older men: Whitehall-1 study of London civil servants

Article References: Alcohol consumption and cause-specific mortality in older men: Whitehall-1 study of London civil servants. (n.d.). https://doi.org/10.1007/s10654-026-01465-4

Image Credits: AI Generated

DOI: 10.1007/s10654-026-01465-4

Keywords: alcohol consumption, mortality, older adults, Whitehall study, epidemiology, cardiovascular disease, cancer, sick-quitter bias, cohort study, public health, hazard ratio, ageing

The technology at the heart of this development is the proteomic aging clock, a statistical model trained to estimate biological age from the levels of thousands of proteins circulating in blood. While chronological age simply counts the years since birth, biological age reflects the physiological state of the body, and when the estimated biological age exceeds chronological age, researchers speak of accelerated aging. Unlike earlier clocks built on DNA methylation or metabolites, proteomic clocks can be trained separately for individual organs, exploiting the fact that aging does not proceed uniformly across tissues. A kidney-specific clock, for example, has been shown to excel at predicting kidney failure, while a lung-specific clock best predicts chronic obstructive pulmonary disease, demonstrating that these tools capture organ-relevant biology rather than a single systemic signal.

Three recent studies, all drawing on the UK Biobank Pharma Proteomics Project, a dataset of roughly 50,000 adults aged from their late thirties to seventies, have applied these organ-specific clocks to alcohol consumption, and their findings diverge in striking ways. In one study, higher alcohol intake was associated with accelerated aging according to the brain, kidney, and intestine clocks, consistent with alcohol’s well-documented harms. Yet the same study reported negative associations with the lung and artery clocks, implying slower biological aging in those organs among heavier drinkers. A second study went further, observing negative associations between alcohol consumption and the kidney, lung, artery, muscle, and intestine clocks. A third found faster aging across most organs examined, with the intestine clock showing a negative association that failed multiple testing correction.

These contradictions are not trivial. If alcohol genuinely slowed aging in certain organs, it would challenge fundamental assumptions about its health effects. But the discrepancies appear to stem largely from methodological differences rather than from any genuine protective biology. The three studies differ in how they define alcohol exposure, with some using total intake in grams per day and others using drinking frequency, and in what their clocks were trained to predict, whether chronological age or mortality risk. Even the protein sets used to construct the clocks vary, despite all being based on the same Olink measurement platform. When two studies trained their clocks on chronological age using the same biobank and both defined exposure as drinking frequency, their divergent results point to the protein panels themselves, or to differences in how thoroughly socioeconomic factors were statistically adjusted, as the most likely sources of conflict.

Socioeconomic confounding emerges as a particularly powerful explanation. In one of the studies, wine consumption, often associated with higher socioeconomic status, appeared protective against organ aging, whereas beer drinking, more common in lower socioeconomic groups, was linked to accelerated aging even after adjustment for covariates including the Townsend deprivation index, a measure of area-level deprivation. This pattern echoes a broader epidemiological lesson: what looks like a biological effect of a beverage may in fact be a social gradient wearing a biological disguise. The same concern applies to a finding that alcohol consumed with meals was associated with slower aging across multiple organs. While the authors proposed plausible mechanisms involving metabolic timing, gut microbiota modulation, and organ-specific regulation of inflammatory responses, drinking with meals is also more likely to reflect moderate, socially embedded consumption patterns, raising the possibility that confounding rather than physiology drives the apparent benefit.

Biology may nonetheless contribute to the inconsistencies. Different organ-specific clocks likely capture distinct biological processes rather than a single underlying aging construct, depending on the outcome each was trained on. Gut microbiota modulation offers one concrete example: polyphenol-rich beverages such as wine can shift microbial composition and reduce markers of systemic inflammation, which could partly account for the wine-related findings, though lifestyle and dietary confounders remain the more probable drivers. In the case of the brain, both studies that examined it reported a consistent synaptic signature, with enrichment of synapse-related pathways in the clock’s protein composition, yet only one found alcohol consumption associated with brain aging. That suggests the inconsistency there arises from methodological choices, such as the difference between measuring total intake and drinking frequency, rather than from divergent biology. Direct comparisons of the functional underpinnings of organ-specific clocks will be needed to separate these threads.

There is also a deeper statistical caveat that applies to every finding in this emerging literature. Organ-specific proteomic clocks rely on protein weights estimated independently of alcohol exposure, meaning the clocks are blind to alcohol when they are built. As a consequence, associations between drinking and clock-based aging estimates may partly reflect the alcohol sensitivity of individual proteins rather than any true effect of alcohol on organ aging. A protein that rises or falls with drinking could shift the clock’s estimate without indicating that the organ itself has aged faster or slower. This subtle property of the method may contribute substantially to the discrepancies observed across studies and complicates any straightforward interpretation of clock-alcohol associations as evidence of harm or benefit.

Despite these limitations, researchers argue that organ-specific aging clocks still offer genuine opportunities to investigate the biological mechanisms through which alcohol contributes to disease, opportunities that remain largely unexplored. Longitudinal study designs could strengthen causal inference, allowing researchers to track how changes in drinking behavior relate to changes in organ aging over time. Yet longitudinal approaches carry their own hazards, most notably the sick-quitter bias, in which individuals stop or drastically reduce drinking on medical advice, contaminating comparisons between drinkers and abstainers. The optimal setting may be biobanks such as FinnGen, where medication use, purchase, and prescription information is available alongside proteomic data, enabling researchers to identify and account for alcohol changes initiated by recent medical recommendations.

The road ahead also points toward combining technologies. Newly developed organ-specific epigenetic clocks could provide an additional biological layer, since epigenetic marks are partially reversible and may capture the long-term imprints of alcohol consumption more faithfully than the proteome, which offers only a snapshot of protein activity at a single time point. Studies directly comparing epigenetic and proteomic clocks are still needed, and the relationship between alcohol’s molecular association with mortality and its effects on the aging process itself remains unclear. Twin and family studies may prove especially informative for disentangling genetic from environmental influences on these associations, given their methodological strengths and the extensive substance-use data accumulated through their historical focus on behavioral traits.

For now, the healthy drinking paradox stands unresolved, but the tools to crack it are finally in hand. The new proteomic studies do not rehabilitate alcohol as a health tonic; if anything, they demonstrate how easily observational data can manufacture the illusion of protection through confounding, exposure misclassification, and methodological noise. What they offer instead is a roadmap: standardized exposure definitions, rigorous socioeconomic adjustment, clock validation across populations, and designs capable of approaching causal inference. Until that work is done, the apparent slowing of aging in the lungs and arteries of heavier drinkers should be read not as a license to drink, but as a cautionary tale about the seductive deceptions lurking in population data, and a reminder that the molecular machinery of aging is only beginning to give up its secrets.

Subject of Research: Organ-specific proteomic aging clocks and the healthy drinking paradox in alcohol epidemiology

Article Title: Organ‐Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox

Article References: Drouard, G. (2026). Organ‐Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox. Aging Cell, 25(10), Article e70743. https://doi.org/10.1111/acel.70743

Image Credits: AI Generated

DOI: 10.1111/acel.70743

Keywords: proteomic aging clocks, alcohol consumption, healthy drinking paradox, biological age, UK Biobank, organ-specific aging, socioeconomic confounding, sick-quitter bias, epigenetic clocks, gut microbiota, wine and beer, Aging Cell